Pricing problems: Aurobindo Pharma, Sun Pharma, Lupin named in lawsuit in US

HYDERABAD: Aurobindo Pharma, Sun Pharma and Lupin are among the 26 drug makers facing a multi-state lawsuit filed in USA by Maryland Attorney General for alleged “conspiracy to artificially inflate and manipulate prices, reduce competition, and unreasonably restrain trade for generic drugs sold across the United States.”

Attorney General Brian E Frosh in a statement issued on Wednesday said the new complaint, filed in the U.S. District Court for the District of Connecticut, focuses on 80 topical generic drugs that account for billions of dollars of sales in the United States and the complaint names 26 corporate defendants and 10 individual defendants.

The lawsuit seeks damages, civil penalties, and actions by the court to restore competition to the generic drug market.

In addition to Maryland, the suit was joined by the attorneys general of all the other states in the USA.